GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Total Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Assets | ₹11,173 Cr | ₹10,611 Cr | ₹8,778 Cr | ₹7,834 Cr | ₹6,496 Cr |
What is the latest Total Assets ratio of GLAND PHARMA ?
| Year | Total Assets |
|---|---|
| Mar2025 | ₹11,173 Cr |
| Mar2024 | ₹10,611 Cr |
| Mar2023 | ₹8,778 Cr |
| Mar2022 | ₹7,834 Cr |
| Mar2021 | ₹6,496 Cr |
How is Total Assets of GLAND PHARMA Trending?
| Years | Total Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹11,173 Cr | 5.30 | |
| Mar2024 | ₹10,611 Cr | 20.89 | |
| Mar2023 | ₹8,778 Cr | 12.05 | |
| Mar2022 | ₹7,834 Cr | 20.59 | |
| Mar2021 | ₹6,496 Cr | - | |
Compare Total Assets of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹30,770.6 Cr | 2.5% | 3.8% | 21.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,185.0 Cr | 3.5% | 12.3% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,766.0 Cr | 2.8% | 7.2% | 7.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,923.0 Cr | 3.8% | 12.1% | 42.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,081.0 Cr | 3% | 9.1% | 11.6% | Stock Analytics | |
| CIPLA | ₹109,680.0 Cr | 1.2% | 2.8% | -9.1% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 2.5% |
3.8% |
21.4% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
You may also like the below Video Courses